Insider Transactions in Q2 2024 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2024
|
Christopher R Gordon |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Douglas E. Giordano |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Norbert G Riedel |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+15.61%
|
-
|
|
Jun 05
2024
|
Deval L Patrick |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Marijn E Dekkers |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+19.83%
|
-
|
|
Jun 05
2024
|
N Anthony Coles |
BUY
Grant, award, or other acquisition
|
Direct |
10,290
+28.41%
|
-
|
|
Jun 05
2024
|
Ruth Mckernan |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Gabrielle Sulzberger |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+15.09%
|
-
|
|
Jun 03
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,000,000
$40.61 P/Share
|
|
Jun 03
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
May 10
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,100,000
$42.1 P/Share
|
|
May 10
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
Apr 01
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,100,000
$42.33 P/Share
|
|
Apr 01
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|